France to Start Covering Cost of Weight-Loss Drugs for Obese Patients
The 65% subsidy will ease access to drugs that cost patients about 300 euros a month, officials said.
- On Thursday, Health Minister Stephanie Rist announced that France will begin partially reimbursing Wegovy and Mounjaro for severely obese patients, with coverage taking effect by mid-June.
- Patients previously paid around €300 monthly out-of-pocket for the injections, as Wegovy and Mounjaro remained available by prescription since 2024 without state reimbursement coverage.
- The reimbursement covers 65 percent for individuals with a BMI of at least 35 and one comorbidity, or a BMI of at least 40; Rist said supplemental insurance will cover 100 percent for most eligible patients.
- "For us, this is excellent news," Anne-Sophie Joly, president of the National Collective of Obesity Associations, told AFP, noting that disadvantaged families struggled to afford the monthly medication.
- "We are the first country in the European Union to provide reimbursement for patients who need it, under general law, on a permanent basis," Rist said, potentially assisting up to one million of the estimated 18 percent obese population.
30 Articles
30 Articles
For patients who are very obese, the French health insurance company will in future cover the costs of the controversial weight loss injections. The cost of this is estimated to be 100 million euros per year, health minister Stéphanie Rist said on Thursday to the channel TF1. France is the first EU country to permanently finance these funds for patients who needed it, she added. At the same time, the minister was in principle in favour of increa…
France to Reimburse Patients for Anti-Obesity Drugs
France is set to begin reimbursing severely obese people for the cost of weight-loss drugs, French Health Minister Stéphanie Rist said on May 28. She said that Paris would subsidize the use of Danish company Novo Nordisk’s Wegovy and American pharma giant Eli Lilly’s Mounjaro from mid-June. “I am quite proud, because we are the first country in the European Union to provide reimbursement … on a permanent basis,” Rist told French broadcaster TFI.…
Two drugs against obesity will soon be reimbursed to French patients by the Health Insurance. Wegovy and Mounjaro, these new treatments, have become planetary phenomena, says franceinfo. Stéphanie Rist, the Minister of Health, has... Read more Anti-obesity medicines: Wegovy and Mounjaro soon reimbursed by the Social Security has appeared first on Current Values.
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
